SEC filing record
Primary Source · SEC.gov

Ikarian Healthcare Offshore Fund, Ltd.

Fund Vehicle2018 vintageRule 506(b), Section 3(c), Section 3(c)(7)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalSold increasedForm D/A · 2026-01-236 events: 3 sold increased, 3 investors increasedLast filing 2026-01-23

Raised

$217M

Investors

102

Min Invest

$100,000

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

Ikarian Healthcare Offshore Fund, Ltd. is a Cayman Islands entity that first filed a Form D on January 22, 2018 and most recently amended it on January 23, 2026, describing itself as a hedge fund. The offering claims Rule 506(b), Section 3(c), Section 3(c)(7) and covers equity and pooled investment fund interests. Ikarian Healthcare Offshore Fund, Ltd. reported $217,456,216 sold from 102 investors in an offering of indefinite size as of the Form D filed January 23, 2026. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $100,000. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 100 Crescent Court, Suite 1620, Dallas, TX 75201.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001728787
Entity NameIkarian Healthcare Offshore Fund, Ltd.
ExemptionRule 506(b), Section 3(c), Section 3(c)(7)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising. Section 3(c) of the Investment Company Act of 1940: the issuer is a pooled investment vehicle relying on an exclusion from registration as an investment company. Section 3(c)(7) of the Investment Company Act: the fund is excluded from investment-company registration because every investor is a qualified purchaser, generally an individual with at least $5 million in investments or an institution with at least $25 million.
Entity TypeOther
Jurisdiction of OrganizationCayman Islands
Issuer Address100 Crescent Court, Suite 1620, Dallas, TX 75201
Phone(214) 276-0670
Industry / Fund TypePooled Investment Fund · Hedge Fund
Investment Company ActExcluded under Section 3(c)(7) (qualified purchasers only)
Securities TypeEquity, Pooled investment fund interests
First Sale DateFebruary 1, 2018
Filing DateJanuary 23, 2026
Accession Number0001728787-26-000001
Total Offering AmountIndefinite
Total Amount Sold$217,456,216
Total Investors102
Non-Accredited InvestorsNone
Minimum Investment$100,000
Offering DurationIntended to last more than one year
Sales Commissions$0
Finders' Fees$0
Net Asset Value RangeDecline to Disclose
State (Issuer Address)TX
Amendment Count9 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

6

latest Jan 23, 2026

Critical / warning

0 / 0

0 watch · 6 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

raising

Latest event Sold increase · Jan 23, 2026

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Fund family Part of the Ikarian Healthcare Fund family: 2 vehicles across 0 generations · adviser of record Ikarian Capital · full family and the filing behind each link in the terminal

Investor

  • The full fund family and any related vehicles (parallel, feeder, successor, sibling series) with the filing that shows each link
  • 6 filing events with values and deltas, latest 2026-01-23, and alerts on the next one
  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Adviser of Record (Form ADV)

Ikarian Capital

CRD 281880 · SEC-registered adviser · lists this fund on Schedule D 7.B.(1) as a hedge fund

Auditor named on Form ADV: PricewaterhouseCoopers LTD. · PCAOB-registered per the adviser

From the adviser's Form ADV as loaded from the SEC bulk data, joined on this issuer's Form D file number. Fund-level figures and the adviser's full fund roster are in the terminal.

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Neil Shahrestani

Executive Officer · DALLAS, TX

Manager of the Investment Manager of the Issuer

Ikarian Capital, LLC

Executive Officer · DALLAS, TX

Investment Manager of the Issuer

Sophia Dilbert

Director · Camana Bay, Grand Cayman, E9

Joe Hardiman

Director · Spring Lake, NJ

Questions About Ikarian Healthcare Offshore Fund, Ltd.

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Ikarian Healthcare Offshore Fund, Ltd.?

Ikarian Healthcare Offshore Fund, Ltd. is a Cayman Islands entity that filed a Form D with the SEC on January 23, 2026 as a hedge fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(7) for an offering of equity and pooled investment fund interests.

Is Ikarian Healthcare Offshore Fund, Ltd. legit?

AltStreet does not rate legitimacy; it reports the public record. Ikarian Healthcare Offshore Fund, Ltd. filed a Form D with the SEC on January 23, 2026 claiming Rule 506(b), Section 3(c), Section 3(c)(7). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $217,456,216 sold to 102 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Ikarian Healthcare Offshore Fund, Ltd. registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Ikarian Healthcare Offshore Fund, Ltd. claimed Rule 506(b), Section 3(c), Section 3(c)(7) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Ikarian Healthcare Offshore Fund, Ltd. raised?

Ikarian Healthcare Offshore Fund, Ltd. reported $217,456,216 sold from 102 investors in an offering of indefinite size as of the Form D filed January 23, 2026.

Who can invest in Ikarian Healthcare Offshore Fund, Ltd.?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $100,000.

What is the minimum investment in Ikarian Healthcare Offshore Fund, Ltd.?

The Form D lists $100,000 as the minimum investment accepted from any outside investor as of January 23, 2026. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling Ikarian Healthcare Offshore Fund, Ltd. and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind Ikarian Healthcare Offshore Fund, Ltd.?

The Form D lists 4 related persons: Neil Shahrestani, executive officer (Manager of the Investment Manager of the Issuer); Ikarian Capital, LLC, executive officer (Investment Manager of the Issuer); Sophia Dilbert, director; Joe Hardiman, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Ikarian Healthcare Offshore Fund, Ltd. located?

The issuer's address on its SEC filings is 100 Crescent Court, Suite 1620, Dallas, TX 75201. Its phone number of record is (214) 276-0670. It is organized under the laws of Cayman Islands.

How long is the Ikarian Healthcare Offshore Fund, Ltd. offering open?

The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 8 amendments are on record for this CIK.

How large is Ikarian Healthcare Offshore Fund, Ltd.?

The issuer declined to disclose its net asset value range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.